Condition
X-Linked
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Completed3
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07414511Recruiting
Hemophilia A Research Program
NCT02317887Phase 1Completed
Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis
NCT04436588Unknown
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature.
NCT02317354Completed
People s Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical Trial
NCT03354403Completed
Mothers Experiences With X-linked Retinoschisis Compared to Fathers Experiences
Showing all 5 trials